tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Veracyte price target raised to $40 from $28 at Morgan Stanley
PremiumThe FlyVeracyte price target raised to $40 from $28 at Morgan Stanley
2M ago
NCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
Premium
The Fly
NCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
2M ago
Veracyte Inc. Reports Robust Q3 Earnings Performance
Premium
Company Announcements
Veracyte Inc. Reports Robust Q3 Earnings Performance
2M ago
Veracyte price target raised to $48 from $42 at UBS
PremiumThe FlyVeracyte price target raised to $48 from $42 at UBS
2M ago
Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
2M ago
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
Premium
Ratings
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
2M ago
VCYT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVCYT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Veracyte initiated with a Hold at Canaccord
Premium
The Fly
Veracyte initiated with a Hold at Canaccord
3M ago
Veracyte initiated with a Buy at Freedom Capital
Premium
The Fly
Veracyte initiated with a Buy at Freedom Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100